- Home
- VRNA vs UGI Comparison
VRNA vs UGI Comparison
Compare VRNA & UGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRNA
- UGI
- Stock Information
- Founded
- VRNA 2005
- UGI 1940
- Country
- VRNA United Kingdom
- UGI United States
- Employees
- VRNA N/A
- UGI N/A
- Industry
- VRNA Biotechnology: Pharmaceutical Preparations
- UGI Natural Gas Distribution
- Sector
- VRNA Health Care
- UGI Utilities
- Exchange
- VRNA Nasdaq
- UGI Nasdaq
- Market Cap
- VRNA 8.3B
- UGI 7.4B
- IPO Year
- VRNA 2017
- UGI N/A
- Fundamental
- Price
- VRNA $106.91
- UGI N/A
- Analyst Decision
- VRNA Buy
- UGI Buy
- Analyst Count
- VRNA 11
- UGI 3
- Target Price
- VRNA $114.10
- UGI $31.33
- AVG Volume (30 Days)
- VRNA 1.5M
- UGI 2.3M
- Earning Date
- VRNA 11-03-2025
- UGI 11-20-2025
- Dividend Yield
- VRNA N/A
- UGI 4.65%
- EPS Growth
- VRNA N/A
- UGI N/A
- EPS
- VRNA N/A
- UGI 1.92
- Revenue
- VRNA $221,673,000.00
- UGI $7,332,000,000.00
- Revenue This Year
- VRNA $909.96
- UGI $10.33
- Revenue Next Year
- VRNA $76.47
- UGI $16.58
- P/E Ratio
- VRNA N/A
- UGI $16.85
- Revenue Growth
- VRNA N/A
- UGI N/A
- 52 Week Low
- VRNA $31.09
- UGI $23.14
- 52 Week High
- VRNA $106.94
- UGI $37.43
- Technical
- Relative Strength Index (RSI)
- VRNA 72.60
- UGI 33.75
- Support Level
- VRNA $105.78
- UGI $32.62
- Resistance Level
- VRNA $106.86
- UGI $32.68
- Average True Range (ATR)
- VRNA 0.16
- UGI 0.53
- MACD
- VRNA -0.04
- UGI -0.01
- Stochastic Oscillator
- VRNA 98.26
- UGI 1.94
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.
About UGI UGI Corporation
UGI Corp is an American holding company that, through its subsidiaries, is involved in the transport and marketing of energy and related services. Its segments include AmeriGas Propane, UGI International, Midstream & Marketing, and Utilities. The AmeriGas Propane segment consists of the propane distribution business. The UGI International segment consists of LPG distribution businesses. The Midstream & Marketing segment consists of energy-related businesses. The Utilities segment consists of the regulated natural gas and electric distribution. The company derives a majority of its revenue from the UGI International segment.